Study on the clinical application in sepsis prevention and treatment with high concentration of hydrogen

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060989

Enrollment

Unknown

Registered

2022-06-15

Start date

2022-01-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

experimental group:high concentrations of hydrogen

control group:oxygen

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with sepsis within 24 hours of admission to ICU (Sepsis 3.0); 2.Aged >= 18 years;3.In line with the ethics, the patients volunteered and signed the informed consent; 4.Admission to ICU for the first time.

Exclusion criteria

Exclusion criteria: 1. Age <18 years old; 2. Patients in terminal state; 3. Pregnant and lactating women; 4. Patients with malignant tumors or radiotherapy and chemotherapy; 5. Patients with mental diseases; 6. Have a history of organ failure such as heart failure, brain failure, liver failure, respiratory failure, renal failure; 7. Refused to participate in the study.

Design outcomes

Primary

Measure	Time frame
Survival at 28 days;	—

Countries

China

Contacts

Public ContactXie Keliang

Tianjin Medical University General Hospital

mzk2011@126.com15332112099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026